The Journal of Immunology, Vol 150, Issue 8 3382-3388, Copyright © 1993 by American Association of Immunologists

ARTICLES

Characterization of the alpha subunit of the IFN-alpha receptor. Evidence of N- and O-linked glycosylation and association with other surface proteins

LC Platanias, LM Pfeffer, R Cruciani and OR Colamonici
Department of Medicine University of Chicago, Pritzker School of Medicine, IL 68637.

We studied the association of the alpha subunit of the (IFN-alpha- receptor) to other receptor components in the human H-929 and U-266 myeloma cell lines. Immunoprecipitation performed with the IFNaR3 mAb showed that two proteins with molecular masses of 205 and 145 kDa are co-precipitated with the alpha subunit. These complexes may not bind IFN-alpha as shown by studies using the heterobifunctional cross- linking reagent Denny-Jaffe and by partial cleavage of the homobifunctional cross-linker dithio succinimidyl propionate. These studies also provided evidence that at least two subunits with molecular mass of 130 kDa (alpha subunit) and 110 kDa (including 20 kDa corresponding to IFN-alpha) contribute to the formation of the IFN- alpha-receptor complex. To further characterize the alpha subunit of the IFN-alpha-receptor, immunoprecipitates using the mAb IFNaR3 were sequentially treated with N-glycanase, neuraminidase and O-glycanase. These studies showed that the alpha subunit is heavily glycosylated and has a protein precursor with a molecular mass of 68 kDa. Binding studies provided evidence for high and low affinity binding sites for IFN-alpha 2. Affinity cross-linking experiments under low and high affinity conditions suggest that the high affinity binding site of the IFN-alpha-receptor is formed by a complex containing the alpha subunit, whereas the 110-kDa subunit may bind IFN-alpha 2 under low affinity conditions.

This article has been cited by other articles:

				V. C. Gibbs, M. Takahashi, M. Aguet, and A. Chuntharapai A Negative Regulatory Region in the Intracellular Domain of the Human Interferon-alpha Receptor J. Biol. Chem., November 8, 1996; 271(45): 28710 - 28716. [Abstract] [Full Text] [PDF]

				L. C. Platanias, S. Uddin, P. Domanski, and O. R. Colamonici Differences in Interferon alpha and beta Signaling. INTERFERON beta SELECTIVELY INDUCES THE INTERACTION OF THE alpha AND beta L SUBUNITS OF THE TYPE I INTERFERON RECEPTOR J. Biol. Chem., September 27, 1996; 271(39): 23630 - 23633. [Abstract] [Full Text] [PDF]

				C.-H. Yang, W. Shi, L. Basu, A. Murti, S. N. Constantinescu, L. Blatt, E. Croze, J. E. Mullersman, and L. M. Pfeffer Direct Association of STAT3 with the IFNAR-1 Chain of the Human Type I Interferon Receptor J. Biol. Chem., April 5, 1996; 271(14): 8057 - 8061. [Abstract] [Full Text] [PDF]

				S. Uddin, A. Chamdin, and L. C. Platanias Interaction of the Transcriptional Activator Stat-2 with the Type I Interferon Receptor J. Biol. Chem., October 20, 1995; 270(42): 24627 - 24630. [Abstract] [Full Text] [PDF]